Pre-operative treatment of uterine fibroids approved by European Commission, Shinpoong says

Published: 2012-03-08 06:56:00

Updated: 2012-03-08 06:56:00

Shinpoong Pharmaceutical Co. says the European Commission (EC) has recently granted marketing authorization to Esmya (ulipristal acetate) 5mg tablets as pre-operative treatment of moderate to severe symptoms of uterine fibroids.

Shinpooong signed an exclusive licensing agreement with France based HRA Pharma on December 2010 for Shin Poong Pharm to develop and commercialize ulipristal acetate...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.